Chemours (NYSE:CC) expects 2023 gross sales volumes of titanium dioxide will fall this 12 months, though the TiO2 market ought to steadily enhance because the 12 months progresses, firm executives stated Friday.

The TiO2 outlook ought to enhance as destocking in Europe might be ending quickly, and demand in Asia ought to enhance following the top of the Lunar New Yr, President and CEO Mark Newman stated on the corporate’s post-earnings convention name.

TiO2 is probably the most delicate to financial cycles amongst Chemours’ (CC) product strains, and the corporate’s full-year steerage for $1.2B-$1.3B adjusted EBITDA and adjusted EPS of $3.80-$4.29 – each beneath final 12 months’s $1.36B adjusted EBITDA and $4.66 adjusted EPS however consistent with Wall Road consensus – takes under consideration the efficiency of the worldwide economic system, the corporate stated.

Within the Superior Efficiency Supplies enterprise, the corporate stays bought out in quite a few product strains, Newman stated on the decision.

The CEO additionally stated it’s prudent to proceed investing responsibly in making fluoropolymers, a part of the group of “ceaselessly chemical compounds” that may final 1000’s of years in nature with out degrading.

“Fluorine chemistries are important, and we imagine, primarily based on our know-how, might be made responsibly,” Newman stated in response to the European Union’s consideration of a proposal to ban extensively used PFAS chemical compounds.

Chemours (CC) shares closed +2.5% on Friday after reporting decrease than anticipated This autumn adjusted earnings however in-line steerage for 2023.